BlackLine, Inc. (BL) Market Cap & Valuation Ratios
BlackLine, Inc. (BL) has a market cap of $2.0B, a trailing P/E of 61.1 and a price-to-sales ratio of 2.8, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BLBlackLine, Inc.Follow BL — free
—
Price chart with a free account
- Market cap
- 2.0B
- P/E TTM
- 61.1
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 8 Feb, in 107 days
Peers
software - application · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| BL | 2.0 | 61.1 | 3.0 | 27.1 | 7.4% | +9% | 4% | 2% |
| NCNO | 2.4 | 74.7 | 4.2 | 29.3 | 5.4% | +9% | 8% | 3% |
| GRND | 2.4 | 27.4 | 5.4 | 17.7 | 6.0% | +32% | 30% | 32% |
| DBD | 2.3 | 22.8 | 0.8 | 8.1 | 9.0% | +5% | 6% | 11% |
| ADEA | 2.3 | 19.5 | 5.5 | 10.1 | 8.1% | +24% | 42% | 19% |
| AMPL | 2.2 | — | 5.4 | — | 1.2% | +18% | -25% | -86% |
| SOUN | 2.0 | — | 8.7 | — | -7.7% | +55% | -69% | -67% |
| BTDR | 1.9 | — | 4.0 | 10.0 | — | +128% | 26% | 6% |
| ALKT | 1.7 | — | 4.1 | — | 3.2% | +27% | -7% | -5% |
| LIME | 1.7 | — | — | — | — | — | 4% | — |
| PDFS | 1.7 | 157.3 | 6.7 | 47.1 | -0.1% | +23% | 8% | 4% |
| Median of these 10 | 27.4 | 5.4 | 13.9 | 4.3% | +24% | 7% | 4% |
P/E 61.1 vs. a peer median of 27.4; EV/Sales 3.0 vs. 5.4. BL's own P/E sits at the 51st percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesAMPL and SOUN and BTDR and ALKT and LIME have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
BlackLine, Inc. — questions
- What is BlackLine, Inc.'s market cap?
- $2.0B.
- What is BlackLine, Inc.'s P/E ratio?
- 61.1 on trailing twelve-month earnings to 2026-06-30.
- What is BlackLine, Inc.'s price-to-sales ratio?
- 2.8.
Every figure on this page comes from BlackLine, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.